BIOCRYST PHARMACEUTICALS INC (BCRX): Form 8-K/A filed 2026-08-04
- Accepted by EDGAR
- 2026-08-04 07:01 ET
- Event date
- 2026-06-25
- Accession no.
- 0001171843-26-005168
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.05: Cost Associated with Exit or Disposal Activities
The company committed to an exit or disposal plan, such as a restructuring, facility closure or workforce reduction, under which it expects to incur material charges.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K/A | FORM 8-K/A | f8ka_080326.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.